FivepHusion
Manufacturing · Australia · 1-10 Employees
View Company Info for Free
Overview
Headquarters
34 Australia W, Austinmer, New South Wal...Website
www.fivephusion.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About FivepHusion
FivepHusion is a private Australian biotechnology company focused on developing optimised cancer therapeutics, particularly a novel drug formulation called Deflexifol. This drug aims to enhance the safety and efficacy of standard cancer treatments, specifically targeting solid tumours such as colorectal, pancreatic, and breast cancers, as well as paediatric brain cancers. The company collaborates with the University of Wollongong for research and development, and its vision is to improve patient outcomes and quality of life through innovative cancer therapies. FivepHusion was founded in 2018 and is headquartered in New South Wales, Australia.Explore more
FivepHusion Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is FivepHusion your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
FivepHusion, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on FivepHusion recently announced quarterly report
Click to see if FivepHusion had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once FivepHusion has new funding data
Check out if FivepHusion is spiking on competitors!
Check if FivepHusion has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at FivepHusion
Product Launch: Get notified when FivepHusion launches new products
Recommended Actions
Reach out to Masked Content who joined FivepHusion as Masked Content
Find 3 more new buyers
Compare Similar Companies to FivepHusion
Compare insights from companies similar to FivepHusion, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
FivepHusion is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
FivepHusion is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about FivepHusion.
FivepHusion Tech Stack
A closer look at the technologies used by FivepHusion
See more technologies
FivepHusion News & Media
FivepHusion Announces Strategic Collaboration with Treehill Partners and Syneos Health
Supporting FivepHusion's Global Development and Commercialization Strategy SYDNEY, May 26, 2023 /PRNewswire/ -- FivepHusion, an advanced clinical-stage biotechnology company, today announced its collaboration with Treehill Partners, a New York-based strategic and financial advisory firm specializing in healthcare industry transactions, and Syneos Health® (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, to develop and bring a novel, enhanced chemotherapeutic pr
Read more news
Top Manufacturing Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding FivepHusion
Sign Up For FreeTo access detailed company insights
FivepHusion is a private Australian biotechnology company focused on developing optimised cancer therapeutics, particularly a novel drug formulation called Deflexifol. This drug aims to enhance the safety and efficacy of standard cancer treatments, specifically targeting solid tumours such as colorectal, pancreatic, and breast cancers, as well as p... Read More
